Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3-UPF1 splicing and surveillance

Jiwon Jeong1, Dawon Hong1, Tae Young Park1

  • 1Laboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.

Cell & Bioscience
|March 24, 2026
PubMed

Insights

The SRSF3-UPF1 axis prevents the oncogenic p53β protein isoform. This axis links splicing and RNA surveillance, offering a therapeutic target to restore tumor suppressor p53 function and impede cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Dysregulated tumor suppressor gene expression can promote cancer.
  • The p53β mRNA isoform, produced via alternative splicing, encodes a truncated protein lacking tumor-suppressive activity.

Purpose of the Study:

  • To investigate the roles of splicing factor SRSF3 and RNA surveillance factor UPF1 in regulating p53 mRNA isoform expression.
  • To elucidate the mechanism by which the SRSF3-UPF1 axis prevents the accumulation of the oncogenic p53β isoform.

Main Methods:

  • Identified SRSF3 binding sites within p53 introns.
  • Demonstrated cotranscriptional complex formation of SRSF3 and UPF1.
  • Analyzed p53β mRNA and protein levels following SRSF3 depletion.

Main Results:

  • SRSF3 binds to p53 intron 9, facilitating UPF1 recruitment and p53β mRNA production.
  • SRSF3 depletion elevates p53β mRNA and protein levels.
  • The p53β isoform promotes epithelial-mesenchymal transition, enhancing cell migration and invasion.

Conclusions:

  • The SRSF3-UPF1 axis coordinates splicing and RNA surveillance to prevent oncogenic p53β isoform accumulation.
  • Targeting the SRSF3-UPF1 axis may restore p53 function and inhibit cancer progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K